Friday, November 07, 2025 8:28:36 AM
exwannabe,
Linda had good news she could have disclosed in 2015 regarding the screening hold which, obviously for fiduciary and strategic reasons she chose not to. At that time she said bad actors turned “good news” into “bad news” and that happened because the “good news” was never disclosed to anyone publicly and those privately aware, time has shown us, were obviously not allowed to trade based on this information. This is the logical fit to explain why Mr. Woodford had to be replaced as fiduciary and why insiders with this information never traded shares. The only ones technically able to get around this legally if they came into publicly undisclosed information are the market makers because of their assigned role but even they can’t legally do anything more than provide adequate liquidity which, apart from their greed motivated price setting schemes, now likely is being looked into as much as possible through discovery. Contrary to your claim, lack of public disclosure of “good news” is permitted by healthcare and other regulators, including the SEC, for strategic business reasons as long as there is no financial advantage created and taken by selective disclosure which is the primary determining factor regarding need for material disclosure. The regulations are clear about this and your explanation does not take the fuller picture into account…me thinks on purpose. Best wishes.
Linda had good news she could have disclosed in 2015 regarding the screening hold which, obviously for fiduciary and strategic reasons she chose not to. At that time she said bad actors turned “good news” into “bad news” and that happened because the “good news” was never disclosed to anyone publicly and those privately aware, time has shown us, were obviously not allowed to trade based on this information. This is the logical fit to explain why Mr. Woodford had to be replaced as fiduciary and why insiders with this information never traded shares. The only ones technically able to get around this legally if they came into publicly undisclosed information are the market makers because of their assigned role but even they can’t legally do anything more than provide adequate liquidity which, apart from their greed motivated price setting schemes, now likely is being looked into as much as possible through discovery. Contrary to your claim, lack of public disclosure of “good news” is permitted by healthcare and other regulators, including the SEC, for strategic business reasons as long as there is no financial advantage created and taken by selective disclosure which is the primary determining factor regarding need for material disclosure. The regulations are clear about this and your explanation does not take the fuller picture into account…me thinks on purpose. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
